Pharmaceutical Technology8m
Daiichi Sankyo and AstraZeneca’s Enhertu snubbed by UK’s NICE for third time
The UK’s NICE has rejected a deal for the reimbursement of Daiichi Sankyo and AstraZeneca's breast cancer drug Enhertu for ...
Pharmaceutical Technology19m
AHA 2024: Phase III BROOKLYN trial – safety and efficacy of obicetrapib in HeFH patients
The Phase III BROOKLYN trial saw HeFH patients randomly assigned in a 2:1 ratio to receive either obicetrapib or a placebo ...
Pharmaceutical Technology3h
FDA issues CRL to Astellas’ IZERVAY sNDA for geographic atrophy
The US FDA has issued a CRL for sNDA of Astellas Pharma’s IZERVAY, a treatment for geographic atrophy (GA) secondary to AMD.
Pharmaceutical Technology17h
FDA shares additional draft guidance on CGTs
The FDA has released a draft of new guidance addressing common FAQs about the development of potential CGT treatments.
Pharmaceutical Technology20h
Novo Nordisk Pharmatech Enters a Distribution Agreement with Signet Chemical Corporation
Novo Nordisk Pharmatech has entered an agreement with Signet Chemical Corporation for the distribution of its pharmaceutical range of ...
Pharmaceutical Technology20h
Aclaris Therapeutics secures global rights to Biosion’s antibodies
Aclaris Therapeutics has secured an exclusive license from Biosion for the global rights to two new antibodies.
Pharmaceutical Technology20h
Does Southeast Asia have a growing role in vaccine development?
The upcoming clinical trial conferences will host talks on supply chain resilience, AI’s growing role and forging industry ...
Pharmaceutical Technology23h
Novartis strengthens radiopharma leadership with Ratio Therapeutics deal
Novartis has teamed up with Ratio Therapeutics in a $745m licensing and collaboration agreement to advance ...